Skip to main content

Table 1 Characteristics of non-DM patients with ACS undergoing PCI with or without major adverse cardiac events (MACEs)

From: Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention

Variable All patients (n = 533) With MACE (n = 69) Without MACE (n = 464) p value
Age (year) 59.96 ± 12.65 64.58 ± 11.43 59.27 ± 12.69 0.001
Sex
 Male 361 (67.7) 47 (68.1) 314 (67.7) 0.941
BMI (kg/m2) 24.11 ± 2.70 24.60 ± 2.96 24.04 ± 2.65 0.111
Hypertension 195 (36.6) 40 (58.0) 155 (33.4) <0.001
Smoking 333 (62.5) 48 (69.6) 285 (61.4) 0.192
Prior MI 37 (6.9) 13 (18.8) 24 (5.2) <0.001
Prior PCI 24 (4.5) 7 (10.1) 17(3.7) 0.015
DBP (mmHg) 77.94 ± 13.00 77.88 ± 12.40 77.95 ± 13.11 0.967
SBP (mmHg) 125.53 ± 20.02 126.35 ± 21.78 125.41 ± 19.77 0.716
Heart rate (bpm) 75.36 ± 13.27 77.12 ± 13.50 75.10 ± 13.24 0.240
eGFR (mL min−1 1.73 m−2) 88.60 ± 35.50 87.05 ± 37.31 88.83 ± 35.26 0.697
FBS (mmol/L) 6.37 ± 1.82 6.28 ± 1.35 6.39 ± 1.88 0.652
TC (mmol/L) 3.92 ± 1.08 3.94 ± 0.92 3.92 ± 1.10 0.926
TG (mmol/L) 1.62 ± 1.00 1.47 ± 1.07 1.65 ± 0.99 0.171
HDL (mmol/L) 1.02 ± 0.25 1.04 ± 0.26 1.02 ± 0.25 0.541
LDL (mmol/L) 2.28 ± 0.74 2.30 ± 0.75 2.27 ± 0.74 0.774
Apo A1 (g/L) 1.08 ± 0.18 1.08 ± 0.22 1. 08 ± 0.18 0.894
Apo B (g/L) 0.77 ± 0.23 0.76 ± 0.22 0.77 ± 0.23 0.904
LVEF (%) 54.26 ± 12.34 49.68 ± 12.23 54.94 ± 12.15 0.001
NT-proBNP (pg/mL) 5.86 ± 1.60 6.30 ± 1.82 5.79 ± 1.56 0.013
PLT count (109/L) 192.81 ± 68.17 212.67 ± 82.73 189.86 ± 65.32 0.009
WBC count (109/L) 8.05 ± 3.23 8.38 ± 3.56 8.00 ± 3.18 0.366
Monocyte count (109/L) 0.57 ± 0.32 0.65 ± 0.45 0.55 ± 0.30 0.021
Neutrophile count (109/L) 5.92 ± 3.14 6.36 ± 3.21 5.85 ± 3.13 0.213
HbA1c content (%) 5.60 ± 0.46 5.90 ± 0.33 5.56 ± 0.46 <0.001
GRACE score 110.47 ± 27.13 131.45 ± 24.40 107.35 ± 26.13 <0.001
Medication at discharge
 Aspirin 524 (98.3) 66 (95.7) 458 (98.7) 0.066
 Clopidogrel 527 (98.9) 68 (98.5) 459 (98.9) 0.785
 Statins 430 (80.7) 58 (84.1) 372 (80.2) 0.446
 ACEI/ARB 389 (73.0) 46 (66.7) 343 (73.9) 0.205
 β-blockers 347 (65.1) 42 (60.9) 305 (65.7) 0.429
  1. Data are mean ± SD or n (%)
  2. BMI body mass index, Prior MI prior myocardial infarction, Prior PCI prior percutaneous coronary intervention, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, FBS fasting blood sugar, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Apo-A1 apolipoprotein A1, Apo-B apolipoprotein B, NT-proBNP N-terminal pro-B-type natriuretic peptide, PLT platelets, LVEF left ventricle ejection fraction, WBC white blood cell count, ACEI angiotensin-converting enzyme inhibition, ARB angiotensin receptor blocker, HbA1c hemoglobin A1c, GRACE score Global Registry of Acute Coronary Events (GRACE) score